MedCity News May 15, 2022
Robert Fallon

Government-funded initiatives such as the Cancer Moonshot support not only the primary science that often serves as a foundation for medical advances, but also ensure that patients with rare cancers are not overlooked.

I’ve been a big fan of the Cancer Moonshot since President Biden first championed the initiative when he was serving as Vice President under President Obama. I previously shared my personal experience talking with him about it when I serendipitously bumped into him on the Acela train, and he was gracious enough to have a conversation with me about the future of cancer care and research.

Last month, President Biden announced the reigniting of the Cancer Moonshot. The reinvigorated effort shares goals of the original initiative in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Related Articles:
Could this weight-loss medication help with sleep apnea?
Meet the 9 healthcare leaders on TIME's 'Most Influential People' list
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements
Opinion: Moving the conversation about obesity beyond the scale
Biopharma M&A more than doubled in the first quarter compared to the year prior: report

Share This Article